We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$5.2B
AUM Growth
+$223M
Cap. Flow
+$501M
Cap. Flow %
9.63%
Top 10 Hldgs %
30.56%
Holding
1,228
New
36
Increased
827
Reduced
326
Closed
36
Avg Time Held
7.5 quarters
Top 10 Avg Time Held
7.1 quarters
Top 20 Avg Time Held
5.9 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$30.8M
2
MSFT icon
Microsoft
MSFT
+$27.5M
3
AMZN icon
Amazon
AMZN
+$16.1M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$12.9M
5
TSLA icon
Tesla
TSLA
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 13.99%
3 Consumer Discretionary 13.11%
4 Financials 11.18%
5 Industrials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BF.A icon
1051
Brown-Forman Class A
BF.A
$12.8B
$243K ﹤0.01%
3,597
+79
+2% +$5.66K
2022 Q2
1 quarter
GEF icon
1052
Greif
GEF
$4.46B
$243K ﹤0.01%
4,080
-3
-0.1% -$200
2021 Q2
5 quarters
XRX icon
1053
Xerox
XRX
$373M
$242K ﹤0.01%
18,515
+126
+0.7% +$2.04K
2021 Q1
6 quarters
DAN icon
1054
Dana Inc
DAN
$3.06B
$240K ﹤0.01%
20,969
-459
-2% -$6.96K
2020 Q2
9 quarters
NEU icon
1055
NewMarket
NEU
$8.27B
$240K ﹤0.01%
797
+7
+0.9% +$2.1K
2020 Q2
9 quarters
CIVI icon
1056
DELISTED
Civitas Resources
CIVI
$238K ﹤0.01%
4,146
+116
+3% +$6.83K
2022 Q2
1 quarter
NTLA icon
1057
Intellia Therapeutics
NTLA
$1.67B
$238K ﹤0.01%
4,250
+210
+5% +$13K
2021 Q2
5 quarters
FELE icon
1058
Franklin Electric
FELE
$4.38B
$236K ﹤0.01%
+2,886
New +$246K
2022 Q3
0 quarters
TENB icon
1059
Tenable Holdings
TENB
$4.55B
$232K ﹤0.01%
6,658
+714
+12% +$29.9K
2021 Q4
3 quarters
SJI
1060
DELISTED
South Jersey Industries, Inc.
SJI
$231K ﹤0.01%
6,911
+247
+4% +$8.42K
2022 Q2
1 quarter
BG icon
1061
Bunge Global
BG
$20.7B
$230K ﹤0.01%
2,784
-52
-2% -$4.84K
2022 Q2
1 quarter
BIPC icon
1062
Brookfield Infrastructure
BIPC
$4.51B
$225K ﹤0.01%
5,528
+215
+4% +$9.89K
2022 Q1
2 quarters
EVA icon
1063
DELISTED
Enviva Inc.
EVA
$225K ﹤0.01%
+3,749
New +$252K
2022 Q3
0 quarters
CYTK icon
1064
Cytokinetics
CYTK
$8.57B
$224K ﹤0.01%
+4,626
New +$223K
2022 Q3
0 quarters
BXMT icon
1065
Blackstone Mortgage Trust
BXMT
$1.81B
$223K ﹤0.01%
9,573
+331
+4% +$9.59K
2021 Q2
5 quarters
RHP icon
1066
Ryman Hospitality Properties
RHP
$8.59B
$223K ﹤0.01%
3,025
+108
+4% +$9.02K
2021 Q2
5 quarters
BPMC icon
1067
DELISTED
Blueprint Medicines
BPMC
$222K ﹤0.01%
+3,364
New +$216K
2022 Q3
0 quarters
JBGS icon
1068
JBG SMITH
JBGS
$653M
$222K ﹤0.01%
11,939
-1,178
-9% -$27K
2020 Q2
9 quarters
TRNO icon
1069
Terreno Realty
TRNO
$7.18B
$221K ﹤0.01%
4,164
+144
+4% +$8.66K
2021 Q2
5 quarters
EXAS icon
1070
DELISTED
Exact Sciences
EXAS
$220K ﹤0.01%
6,762
+177
+3% +$7.3K
2020 Q2
9 quarters
GLPI icon
1071
Gaming and Leisure Properties
GLPI
$11.2B
$220K ﹤0.01%
+4,969
New +$245K
2022 Q3
0 quarters
CLR
1072
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$219K ﹤0.01%
3,276
-138
-4% -$9.31K
2022 Q2
1 quarter
ALKS icon
1073
Alkermes
ALKS
$6.67B
$217K ﹤0.01%
9,737
+711
+8% +$18.5K
2022 Q1
2 quarters
DOCS icon
1074
Doximity
DOCS
$5.45B
$217K ﹤0.01%
7,183
+1,076
+18% +$39.4K
2022 Q2
1 quarter
BCPC icon
1075
Balchem Corp
BCPC
$5.41B
$217K ﹤0.01%
1,786
+60
+3% +$7.82K
2021 Q2
5 quarters

Similar funds

Xponance's Q3 2022 Portfolio in Review

As of Q3 2022, Xponance held 1,228 positions worth $5.2B, up 4.5% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance deployed $501M of net new capital in Q3 2022, opening 36 new positions and adding to 827 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinnacle West Capital, an estimated $2.46M trimmed.

  • Xponance's largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.
  • Xponance added most to Apple in Q3 2022, an estimated $30.8M increase.
  • Xponance's biggest Q3 2022 reduction was Pinnacle West Capital, cutting an estimated $2.46M.
  • Xponance fully exited Atlassian in Q3 2022, selling an estimated $2.99M.
  • Xponance's ten largest holdings make up 31% of its $5.2B portfolio in Q3 2022.
  • Xponance opened 36 new positions and closed 36 in Q3 2022.
  • Xponance's portfolio value rose 4.5% quarter-over-quarter to $5.2B.

Based on Xponance's 13F filing for Q3 2022, filed 24 Oct 2022.